Effects of 3-O-Methyldopa, L-3,4-Dihydroxyphenylalanine Metabolite, on Locomotor Activity and Dopamine Turnover in Rats

スポンサーリンク

概要

• 論文の詳細を見る

• It has been well known that 3-O-methyldopa (3-OMD) is a metabolite of L-3,4-dihydroxyphenylalanine (L-DOPA) formed by catechol O-methyltransferase (COMT), and 3-OMD blood level often reaches higher than physiological level in Parkinson’s disease (PD) patients receiving long term L-DOPA therapy. However, the physiological role of 3-OMD has not been well understood. Therefore, in order to clarify the effects of 3-OMD on physiological function, we examined the behavioral alteration in rats based on locomotor activity, and measured dopamine (DA) and its metabolites levels in rats at the same time after 3-OMD subchronic administration. The study results showed that repeated administrations of 3-OMD increased its blood and the striatum tissue levels in those rats, and decreased locomotor activity in a dose dependent manner. Although 3-OMD subchronic administration showed no significant change in DA level in the striatum, DA metabolite levels, such as 3,4-dihydroxyphenylacetic acid (DOPAC), 3-methoxytyramine (3-MT), and homovanillic acid (HVA) were significantly decreased. After 3-OMD washout period (7 d), locomotor activity and DA turnover in those rats returned to normal levels. Furthermore, locomotor activity and DA turnover decreased by 3-OMD administration were recovered to normal level by acute L-DOPA administration. These results suggested that 3-OMD affect to locomotor activity via DA neuron system. In conclusion, 3-OMD itself may have a disadvantage in PD patients receiving L-DOPA therapy.

著者

• Kimura Yasuhiro

  Department Of Biophysics Kanazawa University School Of Medicine

• Kihira Kenji

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• Taogoshi Takanori

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• Onzawa Yoritaka

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• Uzuhashi Kengo

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• Shirasuna Megumi

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• Hirosawa Tasuku

  Division of Clinical Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Hiroshima University

• KIMURA Yasuhiro

  Department of Applied Chemistry, Faculty of Engineering, Kanagawa University

関連論文

• Discrete acetylcholine release from neuroblastoma or hybrid cells overexpressing choline acetyltransferase into the neuromuscular synaptic cleft
• Pharmacokinetic Interaction of Zonisamide in Rats. Effect of Other Antiepileptics on Zonisamide
• Pharmacokinetic Analysis of Amitriptyline and Its Demethylated Metabolite in Serum and Brain of Rats after Acute and Chronic Oral Administration of Amitriptyline
• Gatifloxacin Induces Augmented Insulin Release and Intracellular Insulin Depletion of Pancreatic Islet Cells(Highlighted paper selected by Editor-in-chief,Molecular and Cell Biology)
• Daily Cost of Ophthalmic Solutions for Treating Glaucoma in Japan
• A Case Study on Cyclosporine A in a Patient with Acute Hepatitis
• Advantage of Body Surface Area on Dose Adjustment of Antiepileptic Drugs
• A Novel Synthesis of Poly(germyl ether) by Regioselective Polyaddition of Dichlorogermane with Bisepoxide
• Effects of 3-O-Methyldopa, L-3,4-Dihydroxyphenylalanine Metabolite, on Locomotor Activity and Dopamine Turnover in Rats
• The Mechanisms of Insulin Secretion and Calcium Signaling in Pancreatic β-Cells Exposed to Fluoroquinolones

スポンサーリンク